A 68-year-old phenotypically male patient with 21-hydroxylase deficiency and concomitant adrenocortical neoplasm producing testosterone and cortisol

Masayuki Hayashi, Yuko Kataoka, Yoshihisa Sugimura, Fumiko Kato, Maki Fukami, Tsutomu Ogata, Keiko Homma, Tomonobu Hasegawa, Yutaka Oiso, Hironobu Sasano, Hiroshi Tanaka

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The steroidogenic enzyme 21-hydroxylase is necessary for the synthesis of both glucocorticoids and mineralocorticoids. 21-hydroxylase is a cytochrome P-450 enzyme and is encoded by the gene CYP21A2. Here we report a 68-year-old phenotypically 'male' but genetically female patient with 21-hydroxylase deficiency (21OHD) and the concomitant virilizing adrenocortical carcinoma. This patient grew up as a male and has not encountered any episodes of adrenal insufficiency without glucocorticoid replacement in his lifetime. A chromosome test at admission, however, identified the 46, XX karyotype, and serum 17-hydroxyprogesterone and urine pregnanetriolone and 11β -hydroxyandrostendione were all elevated, consistent with 21OHD. Moreover, serum testosterone was 1.90 ng/ml, much higher than the female standard levels, and serum cortisol was 5.7 μg/ml, slightly lower than standard levels. Genetic analysis identified the patient as a heterozygote of the two pathogenic mutations in the CYP21A2 gene: IVS2- 13C(A)>G and R356W. Magnetic resonance imaging (MRI) revealed the presence of left adrenal tumor measuring 6 cm, which was subsequently diagnosed as adrenocortical carcinoma based on the criteria of Weiss. Immunohistochemical analysis of the tumor specimens revealed the expression of various enzymes involved in testosterone production, including 3β -hydroxysteroid dehydrogenase, 17α -hydroxylase/17,20- lyase, and 17β -hydroxysteroid dehydrogenase. Importantly, the expression of immunoreactive 21-hydroxylase was detected in these tumor cells. The levels of adrenal tumor-derived steroid metabolites were all markedly decreased following the surgery. This is the first report on a virilized 21OHD patient associated with the adrenocortical tumor that produces testosterone. Moreover, the concomitant adrenocortical tumor may ameliorate adrenocortical insufficiency by producing cortisol.

Original languageEnglish
Pages (from-to)75-84
Number of pages10
JournalTohoku Journal of Experimental Medicine
Volume231
Issue number2
DOIs
Publication statusPublished - 07-10-2013

Fingerprint

Steroid 21-Hydroxylase
Hydrocortisone
Testosterone
Tumors
Adrenocortical Carcinoma
Glandular and Epithelial Neoplasms
Glucocorticoids
Neoplasms
3-Hydroxysteroid Dehydrogenases
Serum
Steroid 17-alpha-Hydroxylase
17-alpha-Hydroxyprogesterone
Adrenal Insufficiency
Mineralocorticoids
Enzymes
Heterozygote
Mixed Function Oxygenases
Genes
Karyotype
Cytochrome P-450 Enzyme System

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Hayashi, Masayuki ; Kataoka, Yuko ; Sugimura, Yoshihisa ; Kato, Fumiko ; Fukami, Maki ; Ogata, Tsutomu ; Homma, Keiko ; Hasegawa, Tomonobu ; Oiso, Yutaka ; Sasano, Hironobu ; Tanaka, Hiroshi. / A 68-year-old phenotypically male patient with 21-hydroxylase deficiency and concomitant adrenocortical neoplasm producing testosterone and cortisol. In: Tohoku Journal of Experimental Medicine. 2013 ; Vol. 231, No. 2. pp. 75-84.
@article{90ab14a79f18400984e9c0abc8fd6d82,
title = "A 68-year-old phenotypically male patient with 21-hydroxylase deficiency and concomitant adrenocortical neoplasm producing testosterone and cortisol",
abstract = "The steroidogenic enzyme 21-hydroxylase is necessary for the synthesis of both glucocorticoids and mineralocorticoids. 21-hydroxylase is a cytochrome P-450 enzyme and is encoded by the gene CYP21A2. Here we report a 68-year-old phenotypically 'male' but genetically female patient with 21-hydroxylase deficiency (21OHD) and the concomitant virilizing adrenocortical carcinoma. This patient grew up as a male and has not encountered any episodes of adrenal insufficiency without glucocorticoid replacement in his lifetime. A chromosome test at admission, however, identified the 46, XX karyotype, and serum 17-hydroxyprogesterone and urine pregnanetriolone and 11β -hydroxyandrostendione were all elevated, consistent with 21OHD. Moreover, serum testosterone was 1.90 ng/ml, much higher than the female standard levels, and serum cortisol was 5.7 μg/ml, slightly lower than standard levels. Genetic analysis identified the patient as a heterozygote of the two pathogenic mutations in the CYP21A2 gene: IVS2- 13C(A)>G and R356W. Magnetic resonance imaging (MRI) revealed the presence of left adrenal tumor measuring 6 cm, which was subsequently diagnosed as adrenocortical carcinoma based on the criteria of Weiss. Immunohistochemical analysis of the tumor specimens revealed the expression of various enzymes involved in testosterone production, including 3β -hydroxysteroid dehydrogenase, 17α -hydroxylase/17,20- lyase, and 17β -hydroxysteroid dehydrogenase. Importantly, the expression of immunoreactive 21-hydroxylase was detected in these tumor cells. The levels of adrenal tumor-derived steroid metabolites were all markedly decreased following the surgery. This is the first report on a virilized 21OHD patient associated with the adrenocortical tumor that produces testosterone. Moreover, the concomitant adrenocortical tumor may ameliorate adrenocortical insufficiency by producing cortisol.",
author = "Masayuki Hayashi and Yuko Kataoka and Yoshihisa Sugimura and Fumiko Kato and Maki Fukami and Tsutomu Ogata and Keiko Homma and Tomonobu Hasegawa and Yutaka Oiso and Hironobu Sasano and Hiroshi Tanaka",
year = "2013",
month = "10",
day = "7",
doi = "10.1620/tjem.231.75",
language = "English",
volume = "231",
pages = "75--84",
journal = "Tohoku Journal of Experimental Medicine",
issn = "0040-8727",
publisher = "Tohoku University Medical Press",
number = "2",

}

A 68-year-old phenotypically male patient with 21-hydroxylase deficiency and concomitant adrenocortical neoplasm producing testosterone and cortisol. / Hayashi, Masayuki; Kataoka, Yuko; Sugimura, Yoshihisa; Kato, Fumiko; Fukami, Maki; Ogata, Tsutomu; Homma, Keiko; Hasegawa, Tomonobu; Oiso, Yutaka; Sasano, Hironobu; Tanaka, Hiroshi.

In: Tohoku Journal of Experimental Medicine, Vol. 231, No. 2, 07.10.2013, p. 75-84.

Research output: Contribution to journalArticle

TY - JOUR

T1 - A 68-year-old phenotypically male patient with 21-hydroxylase deficiency and concomitant adrenocortical neoplasm producing testosterone and cortisol

AU - Hayashi, Masayuki

AU - Kataoka, Yuko

AU - Sugimura, Yoshihisa

AU - Kato, Fumiko

AU - Fukami, Maki

AU - Ogata, Tsutomu

AU - Homma, Keiko

AU - Hasegawa, Tomonobu

AU - Oiso, Yutaka

AU - Sasano, Hironobu

AU - Tanaka, Hiroshi

PY - 2013/10/7

Y1 - 2013/10/7

N2 - The steroidogenic enzyme 21-hydroxylase is necessary for the synthesis of both glucocorticoids and mineralocorticoids. 21-hydroxylase is a cytochrome P-450 enzyme and is encoded by the gene CYP21A2. Here we report a 68-year-old phenotypically 'male' but genetically female patient with 21-hydroxylase deficiency (21OHD) and the concomitant virilizing adrenocortical carcinoma. This patient grew up as a male and has not encountered any episodes of adrenal insufficiency without glucocorticoid replacement in his lifetime. A chromosome test at admission, however, identified the 46, XX karyotype, and serum 17-hydroxyprogesterone and urine pregnanetriolone and 11β -hydroxyandrostendione were all elevated, consistent with 21OHD. Moreover, serum testosterone was 1.90 ng/ml, much higher than the female standard levels, and serum cortisol was 5.7 μg/ml, slightly lower than standard levels. Genetic analysis identified the patient as a heterozygote of the two pathogenic mutations in the CYP21A2 gene: IVS2- 13C(A)>G and R356W. Magnetic resonance imaging (MRI) revealed the presence of left adrenal tumor measuring 6 cm, which was subsequently diagnosed as adrenocortical carcinoma based on the criteria of Weiss. Immunohistochemical analysis of the tumor specimens revealed the expression of various enzymes involved in testosterone production, including 3β -hydroxysteroid dehydrogenase, 17α -hydroxylase/17,20- lyase, and 17β -hydroxysteroid dehydrogenase. Importantly, the expression of immunoreactive 21-hydroxylase was detected in these tumor cells. The levels of adrenal tumor-derived steroid metabolites were all markedly decreased following the surgery. This is the first report on a virilized 21OHD patient associated with the adrenocortical tumor that produces testosterone. Moreover, the concomitant adrenocortical tumor may ameliorate adrenocortical insufficiency by producing cortisol.

AB - The steroidogenic enzyme 21-hydroxylase is necessary for the synthesis of both glucocorticoids and mineralocorticoids. 21-hydroxylase is a cytochrome P-450 enzyme and is encoded by the gene CYP21A2. Here we report a 68-year-old phenotypically 'male' but genetically female patient with 21-hydroxylase deficiency (21OHD) and the concomitant virilizing adrenocortical carcinoma. This patient grew up as a male and has not encountered any episodes of adrenal insufficiency without glucocorticoid replacement in his lifetime. A chromosome test at admission, however, identified the 46, XX karyotype, and serum 17-hydroxyprogesterone and urine pregnanetriolone and 11β -hydroxyandrostendione were all elevated, consistent with 21OHD. Moreover, serum testosterone was 1.90 ng/ml, much higher than the female standard levels, and serum cortisol was 5.7 μg/ml, slightly lower than standard levels. Genetic analysis identified the patient as a heterozygote of the two pathogenic mutations in the CYP21A2 gene: IVS2- 13C(A)>G and R356W. Magnetic resonance imaging (MRI) revealed the presence of left adrenal tumor measuring 6 cm, which was subsequently diagnosed as adrenocortical carcinoma based on the criteria of Weiss. Immunohistochemical analysis of the tumor specimens revealed the expression of various enzymes involved in testosterone production, including 3β -hydroxysteroid dehydrogenase, 17α -hydroxylase/17,20- lyase, and 17β -hydroxysteroid dehydrogenase. Importantly, the expression of immunoreactive 21-hydroxylase was detected in these tumor cells. The levels of adrenal tumor-derived steroid metabolites were all markedly decreased following the surgery. This is the first report on a virilized 21OHD patient associated with the adrenocortical tumor that produces testosterone. Moreover, the concomitant adrenocortical tumor may ameliorate adrenocortical insufficiency by producing cortisol.

UR - http://www.scopus.com/inward/record.url?scp=84884836010&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884836010&partnerID=8YFLogxK

U2 - 10.1620/tjem.231.75

DO - 10.1620/tjem.231.75

M3 - Article

C2 - 24077358

AN - SCOPUS:84884836010

VL - 231

SP - 75

EP - 84

JO - Tohoku Journal of Experimental Medicine

JF - Tohoku Journal of Experimental Medicine

SN - 0040-8727

IS - 2

ER -